Entity Common Stock, Shares Outstanding of Aspire Biopharma Holdings, Inc. from Q1 2025 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Aspire Biopharma Holdings, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2025 to Q3 2025.
  • Aspire Biopharma Holdings, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 12, 2025 was 107M shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)

Aspire Biopharma Holdings, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 107M Nov 12, 2025 10-Q/A 2025-11-14
Q2 2025 49.5M Aug 12, 2025 10-Q 2025-08-13
Q1 2025 48.9M Apr 7, 2025 10-K 2025-04-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.